Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 990.85
-25.25 (-2.48%)
Sep 11, 2026, 3:29 PM IST
Orchid Pharma Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Orchid Pharma stock has a consensus rating of "Buy" and an average price target of ₹968.67. The average 1-year stock price forecast is 2.24% lower than the current stock price, while the lowest is ₹900.00 (-9.17%) and the highest is ₹1,061 (+7.08%).
Price Target: ₹968.67 (-2.24%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Orchid Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
14.43B
from 8.11B
Increased by 77.86%
Revenue Next Year
20.04B
from 14.43B
Increased by 38.87%
EPS This Year
11.50
from 5.35
Increased by 115.13%
EPS Next Year
42.00
from 11.50
Increased by 265.22%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.